Results 121 to 130 of about 2,243,245 (285)
ABSTRACT Despite disseminated intravascular coagulation (DIC) and thrombotic microangiopathy (TMA) sharing features of thrombocytopenia, organ dysfunction, and bleeding, the relationship between these two conditions remains unclear. We therefore conducted a post hoc analysis of post‐marketing surveillance data from Japan to evaluate the clinical ...
Naoki Takezako +11 more
wiley +1 more source
Pattern and Prevalence of Acute and Delayed Transfusion Reactions Following Blood Component Therapy
Introduction: The blood transfusion procedure is crucial from a therapeutic standpoint but may cause adverse effects to the patients through acute and delayed adverse transfusion reactions (ATRs).
Abhijeet Ramesh Dhawale +1 more
doaj
FVIIIa Mimetics: New Approaches and Next‐Generation Initiatives
ABSTRACT Emicizumab has revolutionized hemophilia A care, yet limitations regarding the “ceiling” of hemostatic efficacy (equivalent to mild hemophilia) and global access persist. This review critically examines two distinct paradigms shaping the future of care: Innovation and Access. Regarding innovation, we synthesize the latest clinical data on next‐
Tadashi Matsushita +2 more
wiley +1 more source
Clinical aspects of blood transfusion in cats [PDF]
The safe use of transfusion therapy requires proper knowledge on blood groups, blood typing, donor selection, blood collection, transfusion protocols and adverse transfusion reactions.
Arıkan, Şevket +2 more
core
Gene Editing for Haemophilia—The Next Frontier
ABSTRACT The recently approved haemophilia A and B gene therapies via adeno‐associated virus (AAV) showed a promising therapeutic response after a single injection, but there are still limitations, including the potential loss of transgene expression and restriction in adults.
Mirko Pinotti +3 more
wiley +1 more source
ABSTRACT Introduction Efficacy and safety of albutrepenonacog alfa (rIX‐FP) in people with haemophilia B (PwHB) has been previously demonstrated in clinical trials. However, real‐world data insights are required. Aim To describe real‐world effectiveness and tolerability of rIX‐FP in PwHB in Germany.
Johannes Oldenburg +9 more
wiley +1 more source
Background: The goal of hemovigilance is to improve the safety and quality of blood transfusion services. An identification of adverse transfusion reactions (ATRs) will help to take appropriate steps to reduce their incidence and make blood transfusion ...
Riti Tushar Kanti Sinha1 +2 more
doaj
BACKGROUND: Hemovigilance has become one of the important quality check systems of blood transfusion process, but under/non-reporting of transfusion-associated adverse reactions despite the presence of reporting systems emphasize the need to understand ...
Rayaz Ahmad Bhat +5 more
doaj +1 more source
ABSTRACT Introduction Heparin‐induced thrombocytopenia (HIT) is a rare but potentially life‐threatening, immune‐mediated adverse reaction to heparin. PF4‐dependent immunoassays are sensitive screening tests, but they detect both platelet‐activating and nonactivating antibodies; therefore, positive results require interpretation in clinical context and,
Elvira Maličev +4 more
wiley +1 more source

